HypoTears (Novartis Pharmaceutical Corporation)
Welcome to the PulseAid listing for the HypoTears drug offered from Novartis Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceutical Corporation |
NON-PROPRIETARY NAME: | polyvinyl alcohol and polyehtylene glycol 400 |
SUBSTANCE NAME: | POLYVINYL ALCOHOL; POLYETHYLENE GLYCOL 400 |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2005-07-01 |
END MARKETING DATE: | 0000-00-00 |
HypoTears HUMAN OTC DRUG Details:
Item Description | HypoTears from Novartis Pharmaceutical Corporation |
LABELER NAME: | Novartis Pharmaceutical Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 10(mg/mL; mg/mL) |
START MARKETING DATE: | 2005-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0519_1f11fbef-9c86-c646-a1f9-cdff7fea102f |
PRODUCT NDC: | 0078-0519 |
APPLICATION NUMBER: | part349 |
Other POLYVINYL ALCOHOL; POLYETHYLENE GLYCOL 400 Pharmaceutical Manufacturers / Labelers: